Filter
2615
Filtered Results: 2615
Text search:
Surveillance
and
Epidemiology
Featured
Recommendations
268
New Publications
595
Language
Document type
No document type
1220
Studies & Reports
506
Guidelines
466
Manuals
147
Strategic & Response Plan
146
Fact sheets
47
Situation Updates
40
Training Material
26
Resource Platforms
7
Infographics
7
App
2
Brochures
1
Countries / Regions
Global
136
India
81
Latin America and the Carribbean
69
Western and Central Europe
67
Liberia
61
Africa
60
Sierra Leone
48
Nigeria
46
South Africa
46
Ethiopia
46
Kenya
45
Nepal
41
Uganda
34
Bangladesh
33
Philippines
31
Eastern Europe
31
Zambia
31
Ukraine
29
Brazil
28
Malawi
26
Asia
26
Guinea
25
Rwanda
24
Tanzania
24
South–East Asia Region
22
Russia
22
Ghana
21
Mozambique
20
Congo, Democratic Republic of
20
Germany
19
Myanmar / Burma
18
Zimbabwe
16
Senegal
15
Haiti
15
Syria
14
Namibia
14
Middle East and North Africa
13
Indonesia
13
Cameroon
12
West and Central Africa
12
East and Southern Africa
12
Pakistan
12
Eastern Europe and Central Asia
11
Burkina Faso
10
Venezuela
10
Tajikistan
9
Western Pacific Region
9
Botswana
9
Colombia
8
Lesotho
8
Albania
8
Cambodia
8
Paraguay
8
Thailand
7
USA
7
North America
7
Argentina
7
Vietnam
7
Yemen
7
Mali
7
Angola
7
South Sudan
7
Afghanistan
6
Peru
6
Chile
5
Niger
5
Côte d’Ivoire / Ivory Coast
5
Moldova
5
Chad
5
Madagascar
5
North Macedonia
4
China
4
France
4
Bolivia
4
Lebanon
4
Ecuador
4
Iran
3
Laos
3
Jordan
3
Saudi Arabia
3
Tunisia
3
Spain
3
Sri Lanka
3
Sudan
3
Iraq
3
Somalia
3
Eswatini/ Swaziland
3
Mexico
2
El Salvador
2
Turkey
2
Benin
2
Gambia
2
Togo
2
Kazakhstan
2
Kyrgyzstan
2
Morocco
2
Qatar
2
Mauritania
2
Armenia
2
Belarus
2
Bosnia and Herzegovina
2
Egypt
2
Central African Republic
2
Honduras
2
Libya
2
Timor Leste/ East Timor
1
Estonia
1
Congo-Brazzaville
1
Uzbekistan
1
Burundi
1
Italy
1
Dominican Republic
1
Guinea-Bissau
1
Uruguay
1
Turkmenistan
1
Jamaica
1
Japan
1
Denmark
1
Maldives
1
Portugal
1
Israel
1
Southern Africa
1
Papua New Guinea
1
Nicaragua
1
Greece
1
Georgia
1
Bhutan
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
854
Clinical Guidelines
254
Public Health
158
Key Resources
118
Women & Child Health
66
Pharmacy & Technologies
37
Capacity Building
29
Toolboxes
COVID-19
297
TB
254
HIV
219
NTDs
173
AMR
156
Rapid Response
136
Ebola & Marburg
113
Mental Health
85
Planetary Health
85
2.0 Rapid Response
72
Malaria
69
NCDs
52
Zika
45
Cholera
44
Polio
35
Global Health Education
33
Pharmacy
32
Caregiver
28
Refugee
23
Conflict
23
Natural Hazards
20
Disability
16
Health Financing Toolbox
14
Specific Hazards
11
Social Ethics
1
Typhoon
1
Lancet Glob Health 2022 Published Online May 24, 2022 https://doi.org/10.1016/S2214-109X(22)00185-1
Many commercial actors use a range of coordinated and sophisticated strategies to protect business interests— their corporate playbook—but many of these strategies come at the expense of public h...
Every year, nearly 250 million people move across borders temporarily or permanently for a job opportunity, studying, to flee a crisis back home, or for other reasons. Another 750 million move for similar reasons within the borders of their countries. With the understanding that human mobility affec...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific
The Operational guide: use of referral laboratories for the analysis of foodborne hazards in the Pacific aims to strengthen the food analysis capacity of Pacific Island countries and areas by identifying national and reference laboratories capable of testing for priority foodborne hazards. The Pacif...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
Leptospirosis is a zoonotic disease with epidemic potential, especially after a heavy rainfall,
caused by a bacterium called Leptospira. Leptospira interrogans is pathogenic to humans and
animals, with more than 200 serologic variants or serovars. Humans usually acquire
leptospirosis through dire...
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
Language influences the way we think, how we perceive reality, and how we behave. With respect to HIV, language can embody stigma and discrimination, which impacts access to testing, acquisition of HIV, and engagement with treatment. Language plays a role in supporting respect and empowerment of ind...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
The key areas covered are diagnosis, imaging, pathology, surgery, rehabilitation, palliative care and survivorship. It emphasizes a multi-disciplinary team approach which is paramount for quality cancer care. The specific cancers covered are breast, central nervous system, gastroint...
Interim Version 24, February 2020
This checklist has been prepared with the aim of supporting hospital managers and emergency planners in achieving the above by defining and initiating actions needed to ensure a rapid response to the COVID-19 outbreak. The checklist is structured on eleven key co...
Working document from an informal consultation of experts. A Protocol for risk assessment at the field level. The purpose of document is to provide guidance on the methodology to be used for assessing, at field level, the yellow fever virus circulation in areas at risk, and is primarily intended fo...
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
n October 2019, WHO convened the first meeting of the Buruli ulcer laboratory network (BU-LABNET) in Yaoundé, Cameroon, bringing together 11 laboratories from nine countries at the Pasteur Centre of Cameroon (CPC), the network’s Coordinating Centre. The network was formally established at th...
Since the launch of the 2012–2020 World Health Organization (WHO) road map for the control, elim-ination and eradication of neglected tropical diseases (NTDs) (1), considerable progress against NTDs has been made. Between 2010 and 2020, the number of people requiring interventions against NTDs glo...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
Prepared as an outcome of ICMR Subcommittee on Colorectal Cancer | Coordinated by Division of Non Communicable Diseases | This Consensus Document on Management of Colorectal Cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies,
supportive and palliative ca...
